VitaNova Life Sciences (VNOV) Cash from Financing Activities (2017 - 2025)
VitaNova Life Sciences' (VNOV) quarterly Cash from Financing Activities came in at -$101500.0 in Q2 2025, down 320.55% YoY from $46021.1 in Q2 2024, and down 283.02% on a QoQ basis from -$26500.0 in Q1 2025.
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Cash from Financing Activities (2017 - 2025) Analysis & Trends
VitaNova Life Sciences has disclosed Cash from Financing Activities across 8 years of filings, most recently posting -$101500.0 for Q2 2025.
- Cash from Financing Activities for Q2 2025 came in at -$101500.0, down 320.55% year-over-year; the trailing twelve-month figure through Jan 2026 was -$101500.0 (down 236.49% YoY), and the FY2025 annual result was -$3000.0, down 100.31% from the prior year.
- Cash from Financing Activities for Q2 2025 stood at -$101500.0, down from -$26500.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $958913.0 in Q1 2024 and bottomed at -$101500.0 in Q2 2025.
- Average Cash from Financing Activities over 4 years is $82662.1, with a median of $9853.0 recorded in 2021.
- The widest annual swing landed in 2024, when Cash from Financing Activities jumped 23872.82%; it then plunged 320.55% in 2025.
- Year by year, Cash from Financing Activities stood at $12100.0 in 2021, then slumped by 33.96% to $7991.0 in 2023, then surged by 806.02% to $72400.0 in 2024, then slumped by 240.19% to -$101500.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$101500.0 (Q2 2025), -$26500.0 (Q1 2025), and $72400.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | -1.77 Bn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | -114.00 Mn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | -545.98 Mn |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | -141.00 Mn |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | -200.52 Mn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | -440.95 Mn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | -75.28 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | -133.99 Mn |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | -52.49 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2025 | -101,500.00 |
| Jan 31, 2025 | -26,500.00 |
| Oct 31, 2024 | 72,400.00 |
| Jul 31, 2024 | 52,600.00 |
| Apr 30, 2024 | -24,135.00 |
| Jan 31, 2024 | 958,913.00 |
| Oct 31, 2023 | 7,991.00 |
| Jul 31, 2023 | 17,419.00 |
| Jan 31, 2023 | 4,000.00 |
| Oct 31, 2021 | 12,100.00 |
| Jul 31, 2021 | 6,942.00 |
| Jan 31, 2021 | 11,715.00 |
| Oct 31, 2020 | 30,571.00 |
| Apr 30, 2020 | 14,797.00 |
| Jan 31, 2020 | 7,215.00 |
| Oct 31, 2019 | 11,683.00 |
| Jul 31, 2019 | 19,884.00 |
| Apr 30, 2019 | 13,596.00 |
| Jan 31, 2019 | 36,696.00 |
| Oct 31, 2018 | -12,600.00 |